1. Flexibilities in controlled substances prescribing and dispensing during the COVID-19 pandemic Publication: Washington, D.C. : Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, August 2022 Subject(s): Controlled Substances -- supply & distributionCOVID-19Electronic PrescribingFederal GovernmentHealth Services AccessibilityOpiate Substitution TreatmentState GovernmentUnited States
